Free Trial

Man Group plc Sells 35,397 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Man Group plc cut its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 24.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 110,613 shares of the company's stock after selling 35,397 shares during the period. Man Group plc's holdings in Ryan Specialty were worth $7,097,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Ryan Specialty by 5.7% in the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock worth $633,933,000 after purchasing an additional 529,631 shares during the last quarter. Bessemer Group Inc. lifted its stake in Ryan Specialty by 2.5% in the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock worth $210,651,000 after acquiring an additional 79,976 shares during the period. Blair William & Co. IL lifted its stake in Ryan Specialty by 0.6% in the fourth quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after acquiring an additional 16,540 shares during the period. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after acquiring an additional 981,505 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Ryan Specialty by 2.7% in the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after acquiring an additional 46,960 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Insider Activity at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock opened at $70.20 on Tuesday. The firm has a market capitalization of $18.42 billion, a P/E ratio of 101.74, a PEG ratio of 1.19 and a beta of 0.68. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a 50 day moving average price of $70.18 and a 200 day moving average price of $68.77. Ryan Specialty Holdings, Inc. has a 52 week low of $52.34 and a 52 week high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Ryan Specialty's revenue was up 25.0% on a year-over-year basis. During the same period last year, the firm posted $0.35 EPS. Sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty's payout ratio is currently 141.18%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on RYAN shares. Wells Fargo & Company lowered their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Royal Bank of Canada lowered their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Barclays decreased their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. Finally, The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and increased their price target for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Ryan Specialty currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.58.

Check Out Our Latest Research Report on RYAN

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines